Compare · NIVF vs VMD
NIVF vs VMD
Side-by-side comparison of NewGenIvf Group Limited (NIVF) and Viemed Healthcare Inc. (VMD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NIVF and VMD operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- VMD is the larger of the two at $465.8M, about 103.2x NIVF ($4.5M).
- NIVF has been more active in the news (7 items in the past 4 weeks vs 2 for VMD).
- VMD has more recent analyst coverage (1 ratings vs 0 for NIVF).
- Company
- NewGenIvf Group Limited
- Viemed Healthcare Inc.
- Price
- $1.34-2.55%
- $12.15+0.50%
- Market cap
- $4.5M
- $465.8M
- 1M return
- -
- +17.62%
- 1Y return
- -
- +86.35%
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- News (4w)
- 7
- 2
- Recent ratings
- 0
- 1
Viemed Healthcare Inc.
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and post-acute respiratory healthcare services to patients in the United States. The company offers respiratory services and related equipment, including non-invasive ventilators; bi-level, continuous, and automatic continuous positive airway pressure (PAP) machines; and oxygen therapy, as well as services of respiratory therapists; and respiratory disease management, neuromuscular care, and oxygen therapy services. It also provides in-home sleep apnea testing services to determine the existence of sleep apnea at home. In addition, the company leases non-invasive and invasive ventilators, PAP machines, percussion vests, oxygen concentrator units, and other respiratory equipment, as well as sells medical equipment and/or patient medical services. Further, it provides therapy and counseling to patients in their homes using its technology. The company was founded in 2006 and is headquartered in Lafayette, Louisiana.
Latest NIVF
- SEC Form 4 filed by Director Siu Wing Fung Alfred
- SEC Form 4 filed by Director Fong Hei Yue Tina
- SEC Form 6-K filed by NewGenIvf Group Limited
- NewGen’s Advanced Cytometry Platform Poised for Major UAE/GCC Expansion with Big Four Valuation of US$19 Million
- SEC Form 6-K filed by NewGenIvf Group Limited
- SEC Form 6-K filed by NewGenIvf Group Limited
- NewGen Issues 3,666,667 New Shares in Connection with Strategic K25.ai Acquisition, Reaches Milestone of US$7.6 Million Market Capitalization
- SEC Form 6-K filed by NewGenIvf Group Limited
- NewGen Increases K25.ai Ownership to 10% in Closed Pre-A Round at US$100 Million Valuation with Total US$10 Million Invested
- SEC Form 6-K filed by NewGenIvf Group Limited
Latest VMD
- Chief Medical Officer Frazier William exercised 10,000 shares at a strike of $1.81 and sold $117,200 worth of shares (10,000 units at $11.72) (SEC Form 4)
- Director Smokoff Timothy sold $229,967 worth of shares (20,000 units at $11.50), decreasing direct ownership by 21% to 75,518 units (SEC Form 4)
- Viemed Healthcare Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Viemed Healthcare Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form 10-Q filed by Viemed Healthcare Inc.
- Viemed Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Viemed Healthcare Announces First Quarter 2026 Financial Results
- SEC Form DEF 14A filed by Viemed Healthcare Inc.
- SEC Form DEFA14A filed by Viemed Healthcare Inc.
- Viemed Healthcare Announces First Quarter 2026 Earnings Conference Call Details